News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biothera Phase II Lung Cancer Trial Fully Enrolled


11/17/2011 7:19:25 AM

EAGAN, Minn.--(BUSINESS WIRE)--Biothera’s Phase II non-small cell lung cancer (NSCLC) clinical trial evaluating Imprime PGG® administered in combination with cetuximab (Erbitux®), carboplatin and paclitaxel has met its goal of 90 patients and is fully enrolled, the company announced today.

Read at BioSpace.com

comments powered by Disqus
Biothera
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES